Skip to main content

Prime Medicine, Inc 10-Q for FY2024 Q1

Prime Medicine, Inc. (PRME)

10-Q 2024-05-10 For: 2024-03-31
View Original
Added on April 07, 2026

About this 10-Q

Prime Medicine, Inc filed this 10-Q on May 10, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$591K
compared with $0 a year earlier
Net loss
$45.76M
compared with a net loss of $39.4M a year earlier
Diluted EPS
-$0.44
compared with -$0.44 a year earlier